(Q58326027)

English

Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection

article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection (English)

0 references

0 references

0 references

0 references

Francesco Caso

3

0 references

Luca Cantarini

object named as

Luca Cantarini

series ordinal

5

0 references

author name string

Antonio Vitale

series ordinal

1

0 references

Donato Rigante

series ordinal

2

0 references

Rossella Franceschini

series ordinal

4

0 references

publication date

27 May 2015

0 references

published in

International Journal of Rheumatic Diseases

0 references

volume

20

0 references

issue

8

0 references

page(s)

1046-1049

0 references

cites work

Behçet's syndrome and the nervous system

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2F1756-185X.12680

retrieved

21 January 2018

Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2F1756-185X.12680

retrieved

21 January 2018

EULAR recommendations for the management of Behçet disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2F1756-185X.12680

retrieved

21 January 2018

Biological treatments in Behçet's disease: beyond anti-TNF therapy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2F1756-185X.12680

retrieved

21 January 2018

Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2F1756-185X.12680

retrieved

21 January 2018

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2F1756-185X.12680

retrieved

21 January 2018

Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2F1756-185X.12680

retrieved

21 January 2018

Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2F1756-185X.12680

retrieved

21 January 2018

Addressing the safety of anakinra in patients with rheumatoid arthritis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2F1756-185X.12680

retrieved

21 January 2018

Identifiers

DOI

10.1111/1756-185X.12680

0 references

PubMed ID

26032112

0 references

(Q58326027)

Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)